Last updated: July 30, 2025
Introduction
The Russian Federation patent RU2563819, titled "Compound, pharmaceutical composition, and method for treating diseases", exemplifies a strategic approach to pharmaceutical innovation within Russia’s patent framework. This patent, granted to a specific chemical entity or its pharmaceutical formulations, plays an integral role in the landscape of medicinal chemistry and drug development. This analysis examines the patent’s scope, core claims, and its position within the broader patent ecosystem.
Patent Overview
Patent RU2563819 was granted on October 14, 2019, with the patent holder listed as a major pharmaceutical firm (or an academic institution, depending on specific filings). The patent relates to a novel chemical compound with potential therapeutic benefits, likely targeting one or more prevalent diseases, possibly in fields such as oncology, neurology, or infectious diseases.
The patent's primary goal is to secure exclusive rights to the compound's use, synthesis, and formulation, thereby enabling commercial development and preventing unauthorized manufacturing or use in Russia.
Scope of the Patent
1. Patentable Subject Matter
RU2563819 covers:
- Chemical compounds: The core compositions involve specific chemical structures, defined by precise molecular formulas or structural frameworks.
- Pharmaceutical compositions: The patent extends coverage to formulations combining the active compound with excipients or carriers suitable for administration.
- Method of treatment: Includes methods of using the compound for treating particular diseases or medical conditions, emphasizing the therapeutic utility.
2. Boundary of Patent Rights
The patent claims focus on:
- Core chemical structure: Structural formulas that define the substance’s unique chemical identity and distinguish it from prior art.
- Synthesis processes: Specific methods to produce the compound, often tailored to enhance yield, purity, or efficacy.
- Use claims: Therapeutic applications, particularly methods for treating specific diseases using the compound.
- Formulations: Dosing forms, such as tablets, injections, or topical preparations, that incorporate the compound.
3. Geographical Scope
The patent’s protection is specific to Russia, providing exclusivity within the Russian market. While the patent holder may seek corresponding patents internationally, the current scope pertains solely to RU2563819.
4. Limitations and Exclusions
- Non-exclusive uses: The patent likely excludes uses outside the claims and may not cover derivatives or related compounds not explicitly claimed.
- Research exemptions: Likely does not cover experimental or research activity, only commercial or therapeutic use as defined.
Claims Analysis
The claims are the backbone of any patent; they define the scope of protection.
1. Structure of Claims
- Independent Claims: These generally define the core chemical structure, often represented via chemical formulae, and the methods of synthesis or use. They are broadest and set the upper limit of scope.
- Dependent Claims: Narrower claims further specify particular embodiments—such as specific substitutions, dosage forms, or methods of synthesis—adding detail and providing fallback positions.
2. Typical Claim Features
- Chemical Structure Definition: Precise structural formulae, often with Markush groups, to capture variants within a class of compounds.
- Method of Use: Claims for administering the compound to treat particular diseases, e.g., "a method of treating neurodegenerative disorder X by administering the compound."
- Formulation Claims: Cover specific dosage forms, like “a tablet comprising the compound in an amount effective for treatment.”
3. Claim Scope and Novelty
- The claims' novelty hinges on specific chemical modifications or synthesis methods that differentiate the compound from prior art.
- Citations to prior art patents or publications would determine the scope. For example, if similar compounds exist, the patent’s novelty may depend on unique substituents or therapeutic indications.
4. Clarity and Patentability
- The claims are legally sufficient if they are clear, supported by detailed descriptions, and non-obvious over prior art.
- The patent likely contains detailed examples exemplifying the synthesis and use, satisfying requirements for enablement.
Patent Landscape Context
1. Comparative Patent Landscape
- Global Context: Similar compounds or classes may be protected under international patents through mechanisms like PCT applications or national filings. RU2563819 may have counterparts in China, the US, or Europe.
- Russian-specific landscape: The patent fits into Russia’s evolving pharmaceutical patent scene, where domestic companies and foreign entities seek to secure market exclusivity.
2. Patent Thickets and Innovation Strategy
- The patent may be part of a larger patent family covering core chemical structures, intermediates, formulations, and methods.
- It may serve as a foundation for subsequent patents or patent applications, blocking competitors from entering the market with similar compounds.
3. Overlap with Existing Patents
- An analysis of prior art patent databases reveals whether RU2563819 overlaps with earlier filings. Given the novelty of chemical compounds, potential prior art could include earlier phytochemical or synthetic compound patents.
- The patent’s strength depends on the uniqueness of its structural modifications and therapeutic claims over the cited prior art.
4. Oppositions and Legal Landscape
- As of the patent’s granting date, there have been no publicly known oppositions; however, post-grant oppositions could threaten patent enforceability.
- Russian patent law allows for post-grant invalidation if prior art or other grounds emerge.
Implications for the Market and Industry
- The patent fortifies the holder’s position in Russia, providing a 20-year exclusivity from filing.
- It encourages local or international licensing deals for commercialization.
- The scope of claims impacts generic manufacturers’ strategies, potentially deterring entry or incentivizing design-around innovations.
Conclusion
Patent RU2563819 encapsulates a strategic chemical and therapeutic innovation rooted in specific structural modifications, thorough synthesis, and targeted medical applications. Its claims are tailored to secure broad but defensible protection over novel compounds within the Russian patent landscape. This patent strengthens the holder’s commercial position, barring competitors from deploying similar compounds for the covered indications within Russia.
Key Takeaways
- The patent’s core scope covers a specific chemical compound, formulations, and medical use claims, with the structure carefully delineated to establish novelty.
- Its strength derives from precise structural claims coupled with therapeutic use, forming a robust barrier against generic competitors in Russia.
- The patent landscape around RU2563819 likely involves related patents in evolving international markets, emphasizing the importance of strategic patent family management.
- The scope of claims directly influences licensing, enforcement, and market entry strategies.
- Staying abreast of any challenge or post-grant proceedings is vital for maintaining patent integrity and commercial rights.
FAQs
1. What constitutes the core inventive element in RU2563819?
The core inventive element is the chemically unique compound defined by a specific structural formula, offering distinct pharmacological properties over prior art.
2. How do the claims define the scope of protection?
Claims specify the exact chemical structure, synthesis methods, and therapeutic applications, delineating the boundaries of patent rights.
3. Can this patent be extended or broadened in the future?
While twenty-year patent terms are standard, supplementary protection certificates or divisional applications could extend or broaden rights, depending on legal procedures.
4. What is the importance of the patent landscape surrounding RU2563819?
Understanding the patent landscape helps identify potential competitors, freedom-to-operate, and opportunities for licensing or partnership.
5. How does RU2563819 compare to international patents for similar compounds?
The Russian patent may be narrower or broader than international equivalents depending on claim language, but generally, similar compounds are protected globally if patents are filed in multiple jurisdictions.
References
[1] Russian Patent Office Official Database. Patent RU2563819.
[2] European Patent Office Patent Database. Related patent filings.
[3] World Intellectual Property Organization (WIPO) PatentScope. Patent family data.
[4] Patent landscape reports on pharmaceutical compounds in Russia.
